نتایج جستجو برای: MECOM

تعداد نتایج: 105  

2016
Chao Shen Ming-Tai Chen Xin-Hua Zhang Xiao-Lin Yin Hong-Mei Ning Rui Su Hai-Shuang Lin Li Song Fang Wang Yan-Ni Ma Hua-Lu Zhao Jia Yu Jun-Wu Zhang

MicroRNA-22 (miR-22) is emerging as a critical regulator in organ development and various cancers. However, its role in normal hematopoiesis and leukaemogenesis remains unclear. Here, we detected its increased expression during monocyte/macrophage differentiation of HL-60, THP1 cells and CD34+ hematopoietic stem/progenitor cells, and confirmed that PU.1, a key transcriptional factor for monocyt...

2010
Dong Xiao Enyuan Wang Jiang Su

By means of secondary biogenic gas generation, Microbially Enhance Coalbed Methane (MECoM) technology is used to improve methane content in coalbed. Methanogen consortium metabolism process is the basic avenue for MECoM to yield methane with some organic compounds in coal. Detailed information about the metabolism process is needed in studying the microbial consortium mechanism. Traditional gas...

2017
Precious Takondwa Makondi Chi-Ming Chu Po-Li Wei Yu-Jia Chang

BACKGROUND Acquired drug resistance to the chemotherapeutic drug irinotecan (the active metabolite of which is SN-38) is one of the significant obstacles in the treatment of advanced colorectal cancer (CRC). The molecular mechanism or targets mediating irinotecan resistance are still unclear. It is urgent to find the irinotecan response biomarkers to improve CRC patients' therapy. METHODS Gen...

Bayat H Ohadi M Valipour E,

Background: We examine the GA-repeat core promoters of MECOM and GABRA3 in human embryonic kidney-293 cell line and show that those GA-repeats have promoter activity,and those different alleles of the repeats can significantly alter gene expression.We propose a novel role for GA-repeat core promoters to regulate gene expression in the genes involved in development and evolution. Materials and M...

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2019

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2018

2017
Eva Obermayr Natalia Bednarz-Knoll Beatrice Orsetti Heinz-Ulrich Weier Sandrina Lambrechts Dan Cacsire Castillo-Tong Alexander Reinthaller Elena Ioana Braicu Sven Mahner Jalid Sehouli Ignace Vergote Charles Theillet Robert Zeillinger Burkhard Brandt

Purpose In 75% of ovarian cancer patients the tumor mass is completely eradicated by established surgical and cytotoxic treatment; however, the majority of the tumors recur within 24 months. Here we investigated the role of circulating tumor cells (CTCs) indicating occult tumor load, which remains inaccessible by established diagnostics. Experimental design Blood was taken at diagnosis (basel...

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2019

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2018

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2017

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید